With the aim of proving the efficacy of integrative medicine in the treatment of both cancer and the side effects caused by conventional medicine, the Tal Center conducts clinical and para-clinical studies, examining the influence of medicinal herbs and their active mechanisms, on cancer cells and the immune system.
The Tal Center's uniqueness lies in its ability to conduct in depth scientific research, mainly as a result of the exceptional partnership the center has established with the Sheba Medical Center - Tel Hashomer. The Sheba Oncology Center, the largest in Israel, has provided the Tal Center with a state-of-the-art laboratory to support its groundbreaking research. This advanced technology enables the in vitro growth of patients' cancer and immune system cells, making it possible to examine their response to anti-cancerous herbs and provide truly personalized medicine; while expanding the Tal Center treatment experience and knowledge-base.
Working closely with oncologists, the Tal Center has begun the process of 'translating' the wisdom of Chinese medicine into western practices, and conducts pioneering, global clinical research in a diverse range of fields, including oncology nutrition, botanical formulas, homeopathy and immunotherapy.
Studies published by Yair Mimon, Tal Center Research Manager, and Scientific Counselor of the International Society for Integrative Oncology (SIO), found that Herbal Formula LCS101 influenced cancer patients in multiple ways.
- The formula killed cancerous cells but didn't harm healthy cells. The formula protected healthy cells from the influences of chemotherapy and encouraged the destruction of cancerous cells.
- The formula strengthens the immune system, particularly the elements that fight the cancerous NK cells. A pioneering clinical study found that using the formula during chemotherapy, significantly decreased the side effects expressed by blood count dropping. Research results were published in the prestigious journal "The Oncologist".
It was further proved that Chinese Acupuncture decreases the side effects that develop during chemotherapy, including nausea, fatigue and pain.
By integrating Western practices with the holistic approaches of Chinese medicine, through unique collaborations with leading centers in Israel and abroad; the Tal Center is transforming vision into reality, and becoming a center for international excellence.
For further information on studies conducted by the Tal Center click here
Cooperating & Collaborating
The Tal Center maintains continuous cooperation with leading hospitals and research centers in the field of integrative medicine, and leads collaboration initiatives of knowledge transfer and shared research projects. These include:
- MD Anderson Cancer Center (Huston Texas)
- Memorial Sloane-Kettering Cancer Center (New York)
- Dana-Farber Cancer Institute (Boston)
- The International Society for Integrative Oncology (SIO)
Spreading the Word
The center invests great efforts in the publication of articles and professional literature in the field of integrative medicine.
Growing the Community
Dr. Noah Samuels, Tal Center Medical Manager, devotes much of his time to the academic arena, teaching in The Tel Aviv University (Departments of Medicine and Nursing), The Hebrew University in Jerusalem and The Teknion in Haifa. With a focus on expanding the integrative medicine research community, Dr. Samuels mentors students writing research papers on the subject, and manages shared research projects (clinical and pre-clinical). In addition, he leads several academic initiatives aimed at distributing the accumulated knowledge, and establishing integrative medicine as an inseparable part of traditional treatment.
Through ground-breaking research, innovative thinking and a firm determination
to find better solutions in the area of integrative oncology, the Tal Center has
broken new grounds and pioneered a movement towards changing the culture of cancer treatment.